Recent advances in vaccine and immunotherapy for COVID-19

32Citations
Citations of this article
103Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The COVID-19 pandemic caused by SARS-CoV-2 has resulted in millions of cases and hundreds of thousands of deaths. Beyond there being no available antiviral therapy, stimulating protective immunity by vaccines is the best option for managing future infections. Development of a vaccine for a novel virus is a challenging effort that may take several years to accomplish. This mini-review summarizes the immunopathological responses to SARS-CoV-2 infection and discusses advances in the development of vaccines and immunotherapeutics for COVID-19.

Cite

CITATION STYLE

APA

Rabaan, A. A., Al-Ahmed, S. H., Sah, R., Al-Tawfiq, J. A., Al-Qaaneh, A. M., Al-Jamea, L. H., … Rodriguez-Morales, A. J. (2020). Recent advances in vaccine and immunotherapy for COVID-19. Human Vaccines and Immunotherapeutics, 16(12), 3011–3022. https://doi.org/10.1080/21645515.2020.1825896

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free